Table 2 Clinical outcomes analysis with propensity score matched cohorts
Outcomes | Total (n = 2602) | MAP(60–65 mmHg) | MAP(> 65 mmHg) | P value |
|---|---|---|---|---|
|  | (n = 1301) | (n = 1301) |  | |
Primary outcome | Â | Â | Â | Â |
30-day mortality | 754 (29.0) | 424 (32.6) | 330 (25.4) | < 0.001 |
60-day mortality | 899 (34.6) | 501 (38.5) | 398 (30.6) | < 0.001 |
100-day mortality | 1001 (38.5) | 551 (42.4) | 450 (34.6) | < 0.001 |
Secondary outcome | Â | Â | Â | Â |
In-hospital mortality | 642 (24.7) | 359 (27.6) | 283 (21.8) | < 0.001 |
ICU-free day in 28days | 25.1 (7.1, 28.0) | 24.6 (3.8, 27.9) | 25.7 (9.6, 28.1) | < 0.001 |
AKI within 48Â h, n (%) | 1580 (60.7) | 807 (62) | 773 (59.4) | 0.185 |
AKI within 7Â day, n (%) | 2096 (80.6) | 1049 (80.6) | 1047 (80.5) | 0.96 |
Urine-output on day 1 (ml) | 1217.0 (650.0, 2010.0) | 1150.0 (640.0, 1880.0) | 1300.0 (665.0, 2170.0) | 0.007 |
Urine-output on day 2 (ml) | 1132.0 (526.5, 1936.0) | 1059.0 (485.0, 1872.0) | 1212.0 (579.2, 2026.0) | 0.013 |
Urine-output on day 3 (ml) | 1179.0 (521.8, 2070.0) | 1160.0 (505.0, 2020.0) | 1195.0 (545.0, 2140.0) | 0.327 |